Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes.
暂无分享,去创建一个
Lutz Heinemann | Diane E. Sutter | L. Heinemann | H. Kurth | C. Kapitza | L. Nosek | U. Hövelmann | Laurence Hirsch | Leszek Nosek | Christoph Kapitza | N. Harvey | L. Hirsch | R. Pettis | Diane E. Sutter | Ronald J. Pettis | Noel G. Harvey | Heinz-Joerg Kurth | Ulrike Hövelmann
[1] M. Prausnitz,et al. Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles. , 2009, Diabetes technology & therapeutics.
[2] A. Berghold,et al. Systematic Review and Meta-analysis of Short-Acting Insulin Analogues in Patients With Diabetes Mellitus , 2006 .
[3] S. Haffner. The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease. , 1998, Endocrine reviews.
[4] I. Conget,et al. Glucose Control and Cardiovascular Disease , 2009, Diabetes Care.
[5] J. Gerich. Clinical significance, pathogenesis, and management of postprandial hyperglycemia. , 2003, Archives of internal medicine.
[6] J. Davidson,et al. Is Hyperglycemia a Causal Factor in Cardiovascular Disease? , 2009, Diabetes Care.
[7] Claude Colette,et al. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). , 2003, Diabetes care.
[8] Michael A. Gibney,et al. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations , 2010, Current medical research and opinion.
[9] Lutz Heinemann,et al. Insulin Pump Therapy: What is the Evidence for Using Different Types of Boluses for Coverage of Prandial Insulin Requirements? , 2009, Journal of diabetes science and technology.
[10] D. Giugliano,et al. Defining the Role of Insulin Lispro in the Management of Postprandial Hyperglycaemia in Patients with Type 2 Diabetes Mellitus , 2008, Clinical drug investigation.
[11] H. Gin,et al. Post-prandial hyperglycemia. post-prandial hyperglycemia and diabetes. , 2000, Diabetes & metabolism.
[12] T. Erlinger,et al. Postchallenge hyperglycemia in a national sample of U.S. adults with type 2 diabetes. , 2001, Diabetes care.
[13] Lutz Heinemann,et al. Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection. , 2011, Diabetes technology & therapeutics.
[14] Scott A. Kaestner,et al. Microneedle-Based Intradermal Delivery Enables Rapid Lymphatic Uptake and Distribution of Protein Drugs , 2010, Pharmaceutical Research.
[15] Ralph A. DeFronzo,et al. From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus , 2009, Diabetes.
[16] J. Meigs,et al. Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus , 2006, Diabetologia.